Effect of homocysteinylation of low density lipoproteins on lipid peroxidation of human endothelial cells

Journal of Cellular Biochemistry

Volumn 92, Issue 2, 2004, Pages 351-360

  Ferretti, Gianna ^a   Bacchetti, Tiziana ^a   Moroni, Cinzia ^a   Vignini, Arianna ^a   Nanetti, Laura ^a   Curatola, Giovanna ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Atherosclerosis; Endothelial cells; Homocysteine; Homocysteine thiolactone; Lipid peroxidation; Low density lipoprotein

Indexed keywords

APOPROTEIN; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; LAURDAN; LOW DENSITY LIPOPROTEIN; TRYPTOPHAN; HYDROGEN PEROXIDE; THIOL DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID PEROXIDATION; NORMAL HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN STRUCTURE; CELL LINE; METABOLISM; SPECTROFLUOROMETRY;

CELL LINE; ENDOTHELIAL CELLS; FLUORESCENCE; HOMOCYSTEINE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; LIPOPROTEINS, LDL; SPECTROMETRY, FLUORESCENCE; SULFHYDRYL COMPOUNDS; TRYPTOPHAN;

EID: 4544308769     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20069     Document Type: Article

References (43)

1. Agullo-Ortuno MT, Albaladejo MD, Parra S, Rodriguez-Manotas M, Fenollar M, Ruiz-Espejo F, Tebar J, Martinez P. 2002. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clin Chim Acta 326:105-112.
2. Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR. 2000. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102:1227-1232.
3. Blom HJ, Kleinveld HA, Boers GH, Demacker PN, Hak-Lemmers HL, Te Poele-Pothoff MT, Trijbels JM. 1995. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest 25:149-154.
4. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT. 1986. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 128:181-209.
5. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. 1998. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55:1449-1455.
6. Colaco CA, Roser BJ. 1994. Atherosclerosis and glycation. Bioessays 16:145-147.
7. Dousset N, Ferretti G, Taus M, Valdiguie P, Curatola G. 1994. Fluorescence analysis of lipoprotein peroxidation. Methods Enzymol 233:459-469.
8. Drunat S, Moatti N, Paul JL, Cogny A, Benoit MO, Demuth K. 2001. Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 268:5287-5294.
9. Ferguson E, Hogg N, Antholine WE, Joseph J, Singh RJ, Parthasarathy S, Kalyanaraman B. 1999. Characterization of the adduct formed from the reaction between homocysteine-thiolactone and low-density lipoprotein: Antioxidant implications. Free Radic Biol Med 26:968-977.
10. Ferretti G, Rabini RA, Bacchetti T, Vignini A, Salvolini E, Ravaglia F, Curatola G, Mazzanti L. 2002. Glycated low density lipoproteins modify platelet properties: A compositional and functional study. J Clin Endocrinol Metab 87:2180-2184.
11. Ferretti G, Bacchetti T, Marotti E, Curatola G. 2003a. Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity. Metabolism 52:146-151.
12. ++-induced oxidation of astrocytes. J Trace Elements Med Biol 17:25-30.
13. Ferretti G, Bacchetti T, Moroni C, Vignini A, Curatola G. 2003c. Copper-induced oxidative damage on astrocytes: Protective effect exerted by human high density lipoproteins. BBA 1685:48-54.
14. Freshney RI. 2000. Culture of animal cells: A manual of basic technique. New York: Wiley-Liss.
15. Gao J, Xue A. 2003. Study on the oxidative injury of ECV304 cell induced by homocysteine. Wei Sheng Yan Jiu 32:20-21.
16. Harker LA, Ross R, Slichter SJ, Scott CR. 1976. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58:731-741.
17. Hennig B, Chow CK. 1988. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis. Free Radic Biol Med 4:99-106.
18. Hu ML. 1994. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:380-385.
19. Huang RF, Huang SM, Lin BS, Wei JS, Liu TZ. 2001. Homocysteine- thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 68:2799-2811.
20. Jakubowski H. 1997. Metabolism of homocysteine-thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272:1935-1942.
21. Jakubowski H. 1999. Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 13:2277-2283.
22. Jakubowski H. 2002. Homocysteine is a protein amino acid in humans. Implication for homocysteine-linked disease. J Biol Chem 277:30425-30428.
23. Jakubowski H, Zhang L, Bardeguez A, Aviv A. 2000. Homocysteine- thiolactone and protein homocysteinylation in human endothelial cells. Implication for atherosclerosis. Circ Res 87:45-51.
24. JiangZY, Hunt JV, Wolff SP. 1992. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384-389.
25. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. 1995. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95:1262-1270.
26. Liu G, Nellaiappan K, Kagan HM. 1997. Irreversible inhibition of lysyl oxidase by homocysteine-thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 272:32370-32377.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall PJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
28. McCully KS. 1993. Chemical pathology of homocysteine. I. Atherogenesis. Ann Clin Lab Sci 23:477-493.
29. McDowell FW, Lang D. 2000. Homocysteine and endothelial dysfunction: A link with cardiovascular disease. J Nutr 130:3693-3728.
30. Mercie P, Garnier O, Lascoste L, Renard M, Closse C, Durrieu F, Marit G, Boisseau RM, Belloc F. 2000. Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 5:403-411.
31. Naruszewicz M, Mirkiewicz E, Oleszewski AJ, McCully KS. 1994. Thiolation of low-density lipoprotein by homocysteine-thiolactone causes increased aggregation and interaction with cultured macrophages. Nutr Metab Cardiovasc Dis 4:70-77.
32. Outinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J, Ribau J, Podor TJ, Weitz JI, Austin R. 1998. Characterization of the stress-inducing effects of homocysteine. Biochem J 332:213-221.
33. Parasassi T, De Stasio G, Ravagnan G, Rusch RM, Gratton E. 1991. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys J 60:179-189.
34. Parasassi T, Bittolo-Bon G, Brunelli R, Cazzolato G, Krasnowska EK, Mei G, Sevanian A, Ursini F. 2001. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-). Free Radic Biol Med 31:82-89.
35. Pirillo A, Zhu W, Norata GD, Zanelli T, Barberi L, Roma P, Catapano AL. 2000. Oxidized lipoproteins and endothelium. Clin Chem Lab Med 38:155-160.
36. Rabini RA, Vignini A, Salvolini E, Staffolani R, Martarelli D, Moretti N, Mazzanti L. 2002. Activation of human aortic endothelial cells by LDL from Type 1 diabetic patients: An in vitro study. Atherosclerosis 165:69-77.
37. Rowley DA, Halliwell B. 1982. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Lett 138:33-36.
38. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. 2002. Oxidized low density lipoprotein-induced apoptosis. BBA 1585:213-221.
39. Starkebaum G, Harlan JM. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77:1370-1376.
40. Suliman ME, Lindholm B, Barany P, Bergstrom J. 2001. Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease. Clin Chem Lab Med 39:734-738.
41. Ueland PM, Refsum H, Beresford SA, Vollset SE. 2000. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72:324-332.
42. Vidal M, Sainte-Marie J, Philippot J, Bienvenue A. 1986. Thiolation of low-density lipoproteins and their interaction with L2C leukemic lymphocytes. Biochimie 68:723-730.
43. Wu LL, Wu JT. 2002. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322:21-28.